Miguel Martín Selected Research

Miguel Martín Research Topics

Disease

82	Breast Neoplasms (Breast Cancer) 05/2022 - 02/2003
40	Neoplasms (Cancer) 01/2022 - 01/2007
8	Neoplasm Metastasis (Metastasis) 04/2022 - 06/2008
5	Disease Progression 09/2021 - 10/2005
5	Triple Negative Breast Neoplasms 01/2020 - 05/2018
4	Cardiotoxicity 01/2022 - 01/2009
4	Pathologic Complete Response 12/2018 - 06/2015
3	Fatigue 10/2021 - 07/2010
3	Circulating Neoplastic Cells 09/2021 - 11/2006
2	Residual Neoplasm 01/2022 - 11/2017
2	Nausea 10/2021 - 01/2020
2	Hand-Foot Syndrome 01/2021 - 05/2014
2	Melanoma (Melanoma, Malignant) 10/2020 - 07/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 02/2011
2	Neutropenia 01/2018 - 03/2007
2	Colorectal Neoplasms (Colorectal Cancer) 03/2016 - 05/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 01/2016
2	Febrile Neutropenia 03/2007 - 07/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Dihydropyrimidine Dehydrogenase Deficiency 08/2021
1	Cholangiocarcinoma 06/2021
1	Necrosis 10/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	COVID-19 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Alopecia (Baldness) 01/2020
1	Vomiting 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2019
1	Communicable Diseases (Infectious Diseases) 01/2019

Drug/Important Bio-Agent (IBA)

20	Hormones (Hormone)IBA 05/2022 - 01/2007
15	AnthracyclinesIBA 01/2022 - 02/2003
13	Docetaxel (Taxotere)FDA Link 06/2021 - 07/2004
10	Capecitabine (Xeloda)FDA Link 01/2022 - 06/2005
9	Trastuzumab (Herceptin)FDA Link 01/2022 - 10/2005
9	Taxoids (Taxanes)IBA 09/2021 - 02/2003
8	Paclitaxel (Taxol)FDA LinkGeneric 05/2019 - 06/2008
7	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2012
7	Pharmaceutical PreparationsIBA 01/2020 - 01/2009
6	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2009
5	human ERBB2 proteinIBA 01/2020 - 01/2013
5	130-nm albumin-bound paclitaxelIBA 06/2019 - 06/2013
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2015 - 06/2008
4	ribociclibIBA 05/2022 - 01/2018
4	thiamine triphosphorate (TTP)IBA 04/2022 - 10/2005
4	Aromatase InhibitorsIBA 01/2022 - 01/2012
4	Fulvestrant (Faslodex)FDA Link 01/2020 - 03/2015
4	PlatinumIBA 01/2020 - 02/2011
4	Phenobarbital (Luminal)FDA Link 05/2018 - 10/2012
4	Estrogen ReceptorsIBA 04/2018 - 10/2012
4	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2013 - 07/2004
3	Letrozole (Femara)FDA LinkGeneric 05/2022 - 03/2015
3	Biological ProductsIBA 09/2021 - 01/2009
3	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2016
3	taxaneIBA 01/2020 - 01/2016
3	Carboplatin (JM8)FDA LinkGeneric 12/2018 - 01/2017
3	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2012
3	Denosumab FDA Link 01/2016 - 10/2013
3	Epirubicin (Ellence)FDA LinkGeneric 11/2015 - 06/2008
3	Fluorouracil (Carac)FDA LinkGeneric 07/2013 - 06/2008
2	palbociclibIBA 01/2022 - 10/2021
2	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 04/2011
2	Circulating Tumor DNAIBA 09/2021 - 12/2019
2	liposomal doxorubicin (Doxil)FDA Link 09/2021 - 07/2010
2	neratinibIBA 06/2020 - 06/2012
2	Anastrozole (Arimidex)FDA LinkGeneric 08/2019 - 01/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2018 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 11/2017 - 01/2013
2	Albumin-Bound Paclitaxel FDA Link 11/2017 - 06/2013
2	Vinorelbine (Navelbine)FDA LinkGeneric 03/2007 - 02/2003
1	Olive OilIBA 01/2022
1	Codon (Codons)IBA 01/2022
1	spartalizumabIBA 01/2022
1	pertuzumabIBA 06/2021
1	pembrolizumabIBA 10/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2020
1	BO-112IBA 10/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	Poly I-CIBA 10/2020
1	NivolumabIBA 10/2020
1	talazoparibIBA 02/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2020
1	olaparibIBA 02/2020
1	lifastuzumab vedotinIBA 01/2020
1	atezolizumabIBA 06/2019
1	Immune Checkpoint InhibitorsIBA 06/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	AntibodiesIBA 01/2019

Therapy/Procedure

48	Therapeutics 01/2022 - 06/2005
34	Drug Therapy (Chemotherapy) 05/2022 - 02/2003
8	Adjuvant Chemotherapy 01/2020 - 01/2007
6	Neoadjuvant Therapy 01/2022 - 08/2009
3	Precision Medicine 05/2019 - 11/2017
3	Radiotherapy 09/2015 - 01/2012
2	Intravenous Infusions 01/2020 - 10/2016
2	Induction Chemotherapy 07/2011 - 07/2010
1	Drug Tapering 01/2021
1	Caloric Restriction 01/2019